We had a relatively high frequency of RUNX1 variants in our cohort compared to previous reports in MDS and AML [15, 35]; this could be due to the inclusion of CMML with a higher frequency of RUNX1 variants. Here, RUNX1 is linked to acute myeloid leukemia.